Literature DB >> 2420826

Ribose metabolism and nucleic acid synthesis in normal and glucose-6-phosphate dehydrogenase-deficient human erythrocytes infected with Plasmodium falciparum.

E F Roth, R M Ruprecht, S Schulman, J Vanderberg, J A Olson.   

Abstract

The metabolism of pentose-phosphate was investigated in Plasmodium falciparum-infected normal and glucose-6-phosphate dehydrogenase (G6PD)-deficient human red blood cells in vitro. 5'-Phosphoribosyl-1-pyrophosphate (PRPP) content of infected normal red blood cells was increased 50-60-fold at the parasite trophozoite growth stage over that of uninfected cells. The PRPP increment in infected G6PD-deficient cells at comparable stage and parasitemia was only 40% of the value in normal infected cells. Red blood cell PRPP synthetase activity did not change during the growth cycle of the parasite and was similar in both normal and G6PD-deficient cells. Reduced glutathione (GSH) content of G6PD-deficient cells under conditions of culture fell to low or undetectable levels. These low levels of GSH were shown to inhibit the function of red blood cell PRPP synthetase, which requires GSH for full activity. Measurements of the incorporation of 1-14C or 6-14C selectively labeled glucose into parasite nucleic acids revealed that in normal infected red cells, approximately 20% of the pentose was produced via the oxidation of glucose-6-phosphate, whereas in infected G6PD-deficient cells (Mediterranean type), none of the pentose was produced via the oxidative pathway. It is concluded that the low level of reduced GSH found in G6PD deficiency and the resultant partial inhibition of PRPP synthetase together with the missing oxidative pathway for ribose phosphate production can account fully for the reduced parasite growth rate in G6PD-deficient red blood cells described previously. Of these two mechanisms, the predominant one is the impaired PRPP synthetase activity due to low GSH levels in enzyme-deficient red blood cells. The contribution to the ribose-phosphate pool by the hexose monophosphate shunt is relatively minor. A co-existing oxidative stress (which is often hypothesized to mediate the destruction of parasitized red blood cells) is not required to explain growth inhibition in this scheme and does not represent the most straight-forward explanation of the data described in this report.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420826      PMCID: PMC424447          DOI: 10.1172/JCI112412

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  PATHWAYS OF CARBOHYDRATE METABOLISM AND THEIR PHYSIOLOGICAL SIGNIFICANCE.

Authors:  B L HORECKER
Journal:  J Chem Educ       Date:  1965-05       Impact factor: 2.979

2.  Metabolic polymorphisms and the role of infectious diseases in human evolution.

Authors:  A G MOTULSKY
Journal:  Hum Biol       Date:  1960-02       Impact factor: 0.553

3.  Purine nucleoside phosphorylase activity of blood. I. Erythrocytes.

Authors:  A A SANDBERG; G R LEE; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808

4.  The action of phosphoglucomutase preparations on ribose 1-phosphate.

Authors:  H KLENOW; B LARSEN
Journal:  Arch Biochem Biophys       Date:  1952-06       Impact factor: 4.013

Review 5.  Oxidative stress and falciparum malaria: a critical review of the evidence.

Authors:  E Roth; C Raventos-Suarez; H Gilbert; D Stump; H Tanowitz; K S Rowin; R L Nagel
Journal:  Prog Clin Biol Res       Date:  1984

6.  The effect of X chromosome inactivation on the inhibition of Plasmodium falciparum malaria growth by glucose-6-phosphate-dehydrogenase-deficient red cells.

Authors:  E F Roth; C Raventos Suarez; A Rinaldi; R L Nagel
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

7.  Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.

Authors:  E Zoref; A De Vries; O Sperling
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

8.  Effect of agents simulating the abnormalities of the glucose-6-phosphate dehydrogenase-deficient red cell on Plasmodium berghei malaria.

Authors:  S Pollack; J N George; W H Crosby
Journal:  Nature       Date:  1966-04-02       Impact factor: 49.962

9.  Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme.

Authors:  E A Usanga; L Luzzatto
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

10.  The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects.

Authors:  G C Yeh; E F Roth; J M Phang; S C Harris; R L Nagel; A Rinaldi
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

View more
  4 in total

1.  Structure of ribose 5-phosphate isomerase from Plasmodium falciparum.

Authors:  Margaret A Holmes; Frederick S Buckner; Wesley C Van Voorhis; Christophe L M J Verlinde; Christopher Mehlin; Erica Boni; George DeTitta; Joseph Luft; Angela Lauricella; Lori Anderson; Oleksandr Kalyuzhniy; Frank Zucker; Lori W Schoenfeld; Thomas N Earnest; Wim G J Hol; Ethan A Merritt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-04-12

Review 2.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

3.  Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro.

Authors:  P A Berman; L Human; J A Freese
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Data mining of the transcriptome of Plasmodium falciparum: the pentose phosphate pathway and ancillary processes.

Authors:  Zbynek Bozdech; Hagai Ginsburg
Journal:  Malar J       Date:  2005-03-18       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.